Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Specific gene silencing using RNAi in cell culture.

Yang C, Qiu L, Xu Z.

Methods Mol Biol. 2011;793:457-77. doi: 10.1007/978-1-61779-328-8_30.

PMID:
21913119
2.

[RNA interference: from origins to a novel tool for gene silencing].

Ortiz-Quintero B.

Rev Invest Clin. 2009 Sep-Oct;61(5):412-27. Review. Spanish.

PMID:
20184102
3.

Promises and challenges in developing RNAi as a research tool and therapy for neurodegenerative diseases.

Xia XG, Zhou H, Xu Z.

Neurodegener Dis. 2005;2(3-4):220-31. Review.

PMID:
16909029
4.

Generation of hairpin-based RNAi vectors for biological and therapeutic application.

Boudreau RL, Davidson BL.

Methods Enzymol. 2012;507:275-96. doi: 10.1016/B978-0-12-386509-0.00014-4. Review.

PMID:
22365779
5.

Vector-based RNAi approaches for stable, inducible and genome-wide screens.

Fewell GD, Schmitt K.

Drug Discov Today. 2006 Nov;11(21-22):975-82. Epub 2006 Sep 26. Review.

PMID:
17055406
6.

[Experimental strategies of the application of RNAi technique in mammalian cells].

Zhang DX, Pan B, Liu B, Li K.

Yi Chuan. 2005 Sep;27(5):839-44. Review. Chinese.

PMID:
16257920
7.

RNA interference--significance and applications.

Stanisławska J, Olszewski WL.

Arch Immunol Ther Exp (Warsz). 2005 Jan-Feb;53(1):39-46. Review.

PMID:
15761375
8.

Expression strategies for short hairpin RNA interference triggers.

Rossi JJ.

Hum Gene Ther. 2008 Apr;19(4):313-7. doi: 10.1089/hum.2008.026. Review.

9.

RNA interference--a silent but an efficient therapeutic tool.

Ramachandran PV, Ignacimuthu S.

Appl Biochem Biotechnol. 2013 Mar;169(6):1774-89. doi: 10.1007/s12010-013-0098-1. Epub 2013 Jan 23. Review.

PMID:
23340870
10.

[The application of RNAi to the medical genetics].

Wu D, Wu BY, Liang HY, Zhong N.

Beijing Da Xue Xue Bao. 2005 Feb 18;37(1):106-11. Review. Chinese.

11.

The silent revolution: RNA interference as basic biology, research tool, and therapeutic.

Dykxhoorn DM, Lieberman J.

Annu Rev Med. 2005;56:401-23. Review.

PMID:
15660519
12.

RNAi therapy for neurodegenerative diseases.

Boudreau RL, Davidson BL.

Curr Top Dev Biol. 2006;75:73-92. Review.

PMID:
16984810
13.

[Therapeutic RNA interference for neurodegenerative diseases].

González-Alegre P.

Rev Neurol. 2008 Dec 16-31;47(12):641-7. Review. Spanish.

14.

[Application of RNAi technology to knockdown gene expression in vivo in mammalians].

Zhang AH, Liu GQ.

Sheng Li Ke Xue Jin Zhan. 2004 Apr;35(2):125-9. Review. Chinese.

PMID:
15285417
15.

Post-transcriptional gene silencing by RNA interference in non-mammalian vertebrate systems: where do we stand?

Sifuentes-Romero I, Milton SL, García-Gasca A.

Mutat Res. 2011 Nov-Dec;728(3):158-71. doi: 10.1016/j.mrrev.2011.09.001. Epub 2011 Sep 13. Review.

PMID:
21930237
16.

Strategies for silencing human disease using RNA interference.

Kim DH, Rossi JJ.

Nat Rev Genet. 2007 Mar;8(3):173-84. Review.

PMID:
17304245
17.

Illuminating the gateway of gene silencing: perspective of RNA interference technology in clinical therapeutics.

Sindhu A, Arora P, Chaudhury A.

Mol Biotechnol. 2012 Jul;51(3):289-302. doi: 10.1007/s12033-011-9456-9. Review.

PMID:
21947958
18.

[RNA interference (RNAi) as novel approach for gene silencing--review].

Hu XX.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Dec;13(6):1141-4. Review. Chinese.

PMID:
16403300
19.

RNA interference (RNAi) in hematology.

Scherr M, Steinmann D, Eder M.

Ann Hematol. 2004 Jan;83(1):1-8. Epub 2003 Oct 22. Review.

PMID:
14574462
20.

Promises and challenges in developing RNAi as a research tool and therapy.

Sioud M.

Methods Mol Biol. 2011;703:173-87. doi: 10.1007/978-1-59745-248-9_12. Review.

PMID:
21125490
Items per page

Supplemental Content

Write to the Help Desk